News

Walgreens Boots Alliance faces significant challenges, including rising inflation, heavy competition, and decreasing ...
Walgreens Boots Alliance will pay more than $300 million as part of an agreement with the Justice Department to settle charges the pharmacy chain helped fuel the opioid crisis by knowingly filling ...
Time is running out for some Walgreens shoppers to file for their part of a proposed class action settlement that accuses the pharmacy chain of overcharging for generic drugs.
Pharmacy chain Walgreens Boots Alliance (NASDAQ:WBA) will be reporting results tomorrow before market open. Here’s what to ...
For the second quarter, Walgreens Boots Alliance announced revenues of $38.6 billion—a 4.1% increase year-over-year. The ...
Walgreens delivered a better-than-expected fiscal second quarter and a smaller loss a month after announcing that it would be ...
A jury convicted Damien D. Huff of various felonies, including first-degree intentional homicide in the death of security ...
The settlement resolves a lawsuit alleging that Walgreens overcharged insured customers by inflating its “usual and customary ...
Walgreens’ second-quarter report is one of its last financial disclosures before the struggling drugstore chain ends its ...
VillageMD has turned out to be a challenging venture for Walgreens, which invested $5.2 billion in 2021 to take a majority ...
Walgreens Boots Alliance Inc (NASDAQ: WBA) on Tuesday reported second-quarter sales of $38.59 billion, up 4.1% year over year ...
Don’t miss your chance to be included in a $100 million class action settlement over the cost of some prescription drugs at Walgreens. The settlement ended a lawsuit that accused Walgreens of ...